Regulatory T cells
Showing 1 - 25 of >10,000
Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))
Not yet recruiting
- Lymphoma Leukemia
- allogeneic CAR19 regulatory T cells (CAR19-tTreg)
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Dec 6, 2022
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)
Recruiting
- Chronic Graft vs Host Disease
- Regulatory T-cell enriched infusion
-
Sevilla, SpainJosé Antonio Pérez Simón
May 20, 2022
Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)
Recruiting
- Aplastic Anemia
- Expanded autologous T regulatory cells
-
London, United KingdomKing's College Hospital
Aug 16, 2022
Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived
Not yet recruiting
- Islet Transplantation
- Infusion of recipient T regulatory cell
- Infusion of concomitant Donor Derived Vertebral Bone Marrow
-
Palo Alto, CaliforniaStanford University
Jul 25, 2023
Liver Transplant Rejection Trial in Chicago (Erythropoietin)
Recruiting
- Liver Transplant Rejection
-
Chicago, IllinoisNorthwestern University
Apr 5, 2022
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
Abdominal Aortic Aneurysm Trial in Indianapolis (MSCs, Placebo)
Terminated
- Abdominal Aortic Aneurysm
- MSCs
- Placebo
-
Indianapolis, IndianaRichard L. Roudebush VA Medical Center, Indianapolis, IN
Aug 4, 2022
End Stage Renal Disease Trial in Lexington (High Intensity Interval Training)
Not yet recruiting
- End Stage Renal Disease
- High Intensity Interval Training
-
Lexington, KentuckyUniversity of Kentucky Transplant Center
Feb 14, 2022
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- CK0803
- Excipient
-
New York, New YorkColumbia University Irving Medical Center
Jan 26, 2023
Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)
Active, not recruiting
- Pemphigus Foliaceus
- Pemphigus Vulgaris
- Cohort 1: 1.0 x 10^8 PolyTregs
- Cohort 2: 2.5x10^8 PolyTregs
-
San Francisco, California
- +3 more
Oct 22, 2021
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)
Completed
- Graft Versus Host Disease
- Allogeneic Hematopoietic Cell Transplant Recipient
- Regulatory T Cells
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 20, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Orca-T
- Standard-of-Care
-
Duarte, California
- +13 more
Jan 25, 2023
GVHD Trial in Stanford (donor regulatory T lymphocytes, laboratory biomarker analysis)
Suspended
- Graft Versus Host Disease
- donor regulatory T lymphocytes
- laboratory biomarker analysis
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Aug 18, 2021
Tregs CD25 CXCL9 in Vitiligo
Not yet recruiting
- Vitiligo
- +3 more
- ELIZA , Flowcytometry
- (no location specified)
Oct 3, 2022
Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)
Recruiting
- Chronic Graft-Versus-Host Disease
- +2 more
- Rapamycin
- T regulatory cells
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Apr 27, 2021
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
-
Stanford, CaliforniaStanford University
Oct 28, 2021
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Liver Transplantation Trial in Boston (Interleukin-2)
Active, not recruiting
- Liver Transplantation
- Interleukin-2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
May 25, 2021
Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)
Completed
- Kidney Failure, Kidney Transplant
- T Regulatory Cell Infusion
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021